Rapid Evolution of a Fragment-like Molecule to Pan-Metallo-Beta-Lactamase Inhibitors: Initial Leads toward Clinical Candidates

发表于 1 小时前

期刊：Journal of Medicinal Chemistry

文献作者：Mihirbaran Mandal; Li Xiao; Weidong Pan; Giovanna Scapin; Guoqing Li; Haiqun Tang; Shu-Wei Yang; Jianping Pan; Yuriko Root; Reynalda Keh de Jesus; Christine Yang; Winnie Prosise; Priya Dayananth; Asra Mirza; Alex G. Therien; Katherine Young; Amy Flattery; Charles Garlisi; Rumin Zhang; Donald Chu; Payal Sheth; Inhou Chu; Jin Wu; Carrie Markgraf; Hai-Young Kim; Ronald Painter; Todd W. Mayhood; Edward DiNunzio; Daniel F. Wyss; Alexei V. Buevich; Thierry Fischmann; Alexander Pasternak; Shuzhi Dong; Jacqueline D. Hicks; Artjohn Villafania; Lianzhu Liang; Nicholas Murgolo; Todd Black; William K. Hagmann; Jim Tata; Emma R. Parmee; Ann E. Weber; Jing Su; Haifeng Tang

出版日期：2022-12-22

DOI号：10.1021/acs.jmedchem.2c00766

下载链接：https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.2c00766

文献链接：https://doi.org/10.1021/acs.jmedchem.2c00766

当前文献来源于 American Chemical Society (ACS)。

备注信息：

发表于 1 小时前

: 当前求助已完成，请重新发起求助。
已完结状态的附件将会在24小时内删除。

[ACS] Rapid Evolution of a Fragment-like Molecule to Pan-Metallo-Beta-Lactamase Inhibitors: Initial Leads toward Clinical Candidates

已采纳

同分类求助

最新回复

站点公告

今日热心研友

（热心研友QQ群）

[ACS] Rapid Evolution of a Fragment-like Molecule to Pan-Metallo-Beta-Lactamase Inhibitors: Initial Leads toward Clinical Candidates 一键复制